|
1.
|
Cardiovascular Disease After Aromatase Inhibitor Use. MedStar authors:
Year: 2016
Citation: - JAMA Oncology. 2(12):1590-1597, 2016 Dec 01
Institution: - MedStar Heart & Vascular Institute
Medline publication type:
All authors: - Amundsen B, Avila C, Barac A, Chlebowski RT, Chung J, Haque R, Schottinger JE, Shi J, Xu X
|
|
2.
|
Major Adverse Cardiovascular Events and the Timing and Dose of Corticosteroids in Immune Checkpoint Inhibitor-Associated Myocarditis. MedStar authors:
- Barac, Ana
- Forrestal, Brian J
Year: 2020
Citation: - Circulation. 141(24):2031-2034, 2020 06 16.
Institution: - MedStar Heart & Vascular Institute
Medline publication type:
All authors: - Alvi RM, Awadalla M, Barac A, Chen CL, Cohen JV, Ederhy S, Forrestal BJ, Fradley MG, Ganatra S, Groarke JD, Gupta D, Hassan MZO, Heinzerling LM, Jones-O'Connor M, Kirchberger MC, Lyon AR, Mahmood SS, Mahmoudi M, Mandawat A, Murphy SP, Neilan TG, Nohria A, Reynolds KL, Rizvi MA, Rokicki A, Sahni G, Shah SP, Sullivan RJ, Thavendiranathan P, Thuny F, Tocchetti CG, Yang EH, Zatarain-Nicolas E, Zhang L, Zlotoff DA, Zubiri L
|
|
4.
|
Cardiovascular toxicity after antiangiogenic therapy in persons older than 65 years with advanced renal cell carcinoma. MedStar authors:
Year: 2016
Citation: - Cancer. 122(1):124-30, 2016 Jan 1.
Institution: - MedStar Heart & Vascular Institute
Medline publication type:
- Journal Article
- Research Support, N.I.H., Extramural
All authors: - Atkins MB, Barac A, Freedman AN, Fu AZ, Jang S, Minasian L, Potosky AL, Tsai HT, Zheng C
|